Malaria kills hundreds of thousands of people every year, mostly babies in sub-Saharan Africa.<br/> <br />This child in Tanzania is taking part in a trial for the world's first malaria vaccine RTS,S<br/> <br />Britain's GlaxoSmithKline is hoping to get marketing approval for the injection next year after the trial significantly cut cases in children.<br/> <br />Scientists say an effective vaccine is key for eradicating malaria.<br/> <br />Doctor Allan Pamba helped carry out the trial for GSK.<br/> <br />SOUNDBITE: Allan Pamba, GSK doctor, saying (English):<br/> <br />"The vaccine reduces by about half the risk of malaria for children between 5 and 17 months and by about a quarter for children 6 - 12 weeks. It's a huge population of children we've been following, about 15,000 across 11 sites in 7 countries across Africa."<br/> <br />If drug regulators give it the green light, the World Health Organisation may recommend use of the vaccine in two years' time.<br/> <br />But getting it to patients won't be easy, says Mark Hollis
